Literature DB >> 25550117

Laparoscopic en bloc excision of gastrointestinal stromal tumors of the rectum after neoadjuvant imatinib therapy: anteriorly extended intersphincteric resection combined with partial resection of the prostate.

T Ueki1, K Nagayoshi, T Manabe, R Maeyama, A Yokomizo, H Yamamoto, Y Oda, M Tanaka.   

Abstract

We herein present a novel technique for laparoscopic en bloc excision involving anteriorly extended intersphincteric resection with partial resection of the posterior lobe of the prostate for large rectal gastrointestinal stromal tumors (GISTs). The sequence of neoadjuvant imatinib therapy and this less invasive surgery for marginally resectable rectal GISTs has the potential to obviate the need for urinary reconstruction and permanent stomas without jeopardizing the tumor margin status.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25550117     DOI: 10.1007/s10151-014-1261-6

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  8 in total

1.  Laparoscopic versus open intersphincteric resection and coloanal anastomosis for low rectal cancer: intermediate-term oncologic outcomes.

Authors:  Jun Seok Park; Gyu-Seog Choi; Soo Han Jun; Suguru Hasegawa; Yoshiharu Sakai
Journal:  Ann Surg       Date:  2011-12       Impact factor: 12.969

Review 2.  Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Authors:  P G Casali; L Jost; P Reichardt; M Schlemmer; J-Y Blay
Journal:  Ann Oncol       Date:  2009-05       Impact factor: 32.976

3.  The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour.

Authors:  S Machlenkin; I Pinsk; H Tulchinsky; Y Ziv; J Sayfan; D Duek; M Rabau; S Walfisch
Journal:  Colorectal Dis       Date:  2011-10       Impact factor: 3.788

4.  Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum.

Authors:  Yoshiya Fujimoto; Takashi Akiyoshi; Tsuyoshi Konishi; Satoshi Nagayama; Yosuke Fukunaga; Masashi Ueno
Journal:  Int J Colorectal Dis       Date:  2013-09-10       Impact factor: 2.571

5.  Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour.

Authors:  P Hohenberger; U Ronellenfitsch; O Oladeji; D Pink; P Ströbel; E Wardelmann; P Reichardt
Journal:  Br J Surg       Date:  2010-08-20       Impact factor: 6.939

6.  Colorectal gastrointestinal stromal tumor.

Authors:  A Amato
Journal:  Tech Coloproctol       Date:  2010-11       Impact factor: 3.781

7.  Abdominoperineal excision with partial anterior en bloc resection in multimodal management of low rectal cancer: a strategy to reduce local recurrence.

Authors:  Kennet Smedh; Maziar Hosseinali Khani; Wolfgang Kraaz; Yngve Raab; Eva Strand
Journal:  Dis Colon Rectum       Date:  2006-06       Impact factor: 4.585

8.  Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach.

Authors:  Abbas Agaimy; Nikolaos Vassos; Bruno Märkl; Norbert Meidenbauer; Jens Köhler; Johann Spatz; Werner Hohenberger; Florian Haller; Roland S Croner; Regine Schneider-Stock; Klaus Matzel
Journal:  Int J Colorectal Dis       Date:  2013-02-13       Impact factor: 2.571

  8 in total
  5 in total

Review 1.  Neoadjuvant imatinib therapy in rectal gastrointestinal stromal tumors.

Authors:  Manabu Kaneko; Shigenobu Emoto; Koji Murono; Hirofumi Sonoda; Masaya Hiyoshi; Kazuhito Sasaki; Yasutaka Shuno; Takeshi Nishikawa; Toshiaki Tanaka; Keisuke Hata; Kazushige Kawai; Hiroaki Nozawa
Journal:  Surg Today       Date:  2018-11-15       Impact factor: 2.549

2.  Clinical outcomes of surgical and imatinib treatment for rectal gastrointestinal stromal tumours: retrospective cohort study.

Authors:  Shunsuke Tsukamoto; Yoshitaka Honma; Hirokazu Shoji; Hidekazu Hirano; Manabu Inoue; Yasuyuki Takamizawa; Konosuke Moritani; Jun Imaizumi; Yukihide Kanemitsu
Journal:  BJS Open       Date:  2022-05-02

3.  Diagnosis and treatment of gastrointestinal stromal tumor extending to prostate: A case report and literature review.

Authors:  Huan Xu; Chong Liu; Yanbo Chen; Meng Gu; Zhikang Cai; Qi Chen; Zhong Wang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

4.  Neoadjuvant tyrosine kinase inhibitors in rectal gastrointestinal stromal tumours: a provision for enhanced oncological and functional outcomes.

Authors:  Zachary Zihui Yong; Jolene Si Min Wong; Melissa Ching Ching Teo; Claramae Shulyn Chia; Chin-Ann Johnny Ong; Mohamad Farid; Grace Hwei Ching Tan
Journal:  Int J Clin Oncol       Date:  2021-02-02       Impact factor: 3.402

Review 5.  Recent Advancements in the Treatment of Rectal Gastrointestinal Stromal Tumor: In Era of Imatinib.

Authors:  Hui Qu; ZhaoHui Xu; YanYing Ren; ZeZhong Gong; Ri Hyok Ju; Fan Zhang; HaoNan Kang; Yang Xu; Xin Chen
Journal:  Cancer Manag Res       Date:  2022-03-16       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.